[go: up one dir, main page]

PL3067349T3 - Pochodna karboksymetylopiperydyny - Google Patents

Pochodna karboksymetylopiperydyny

Info

Publication number
PL3067349T3
PL3067349T3 PL14860761T PL14860761T PL3067349T3 PL 3067349 T3 PL3067349 T3 PL 3067349T3 PL 14860761 T PL14860761 T PL 14860761T PL 14860761 T PL14860761 T PL 14860761T PL 3067349 T3 PL3067349 T3 PL 3067349T3
Authority
PL
Poland
Prior art keywords
piperidine derivative
carboxymethyl piperidine
carboxymethyl
derivative
piperidine
Prior art date
Application number
PL14860761T
Other languages
English (en)
Inventor
Kazuo Shimizu
Takashi Miyagi
Kohsuke Ohno
Yasunori Ueno
Yusuke ONDA
Hikaru Suzuki
Original Assignee
Kissei Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical Co., Ltd. filed Critical Kissei Pharmaceutical Co., Ltd.
Publication of PL3067349T3 publication Critical patent/PL3067349T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL14860761T 2013-11-08 2014-11-06 Pochodna karboksymetylopiperydyny PL3067349T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013231773 2013-11-08
EP14860761.7A EP3067349B1 (en) 2013-11-08 2014-11-06 Carboxymethyl piperidine derivative
PCT/JP2014/079384 WO2015068744A1 (ja) 2013-11-08 2014-11-06 カルボキシメチルピペリジン誘導体

Publications (1)

Publication Number Publication Date
PL3067349T3 true PL3067349T3 (pl) 2018-06-29

Family

ID=53041521

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14860761T PL3067349T3 (pl) 2013-11-08 2014-11-06 Pochodna karboksymetylopiperydyny

Country Status (15)

Country Link
US (1) US10100030B2 (pl)
EP (1) EP3067349B1 (pl)
JP (1) JP5806420B1 (pl)
KR (1) KR20160078997A (pl)
CN (1) CN105745198B (pl)
AU (1) AU2014347644B2 (pl)
BR (1) BR112016009811A2 (pl)
CA (1) CA2930008A1 (pl)
ES (1) ES2671418T3 (pl)
IL (1) IL245286B (pl)
MX (1) MX368070B (pl)
PL (1) PL3067349T3 (pl)
RU (1) RU2673084C2 (pl)
TW (1) TWI657082B (pl)
WO (1) WO2015068744A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI649307B (zh) 2014-05-07 2019-02-01 日商橘生藥品工業股份有限公司 Cyclohexylpyridine derivative
WO2016021562A1 (ja) * 2014-08-06 2016-02-11 キッセイ薬品工業株式会社 シアノチオフェン誘導体
KR20180090302A (ko) * 2015-12-07 2018-08-10 깃세이 야쿠힌 고교 가부시키가이샤 Nk1 수용체 길항제
CN109312045B (zh) 2016-06-21 2021-08-24 Dic株式会社 醇改性聚酰胺酰亚胺树脂及其制造方法
PE20221167A1 (es) 2019-11-15 2022-07-25 Kandy Therapeutics Ltd Nuevo proceso quimico para la elaboracion de 6-cloro-4-(4-fluoro-2-metilfenil)piridin-3-amina, un intermediario clave de nt-814

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0008494A (pt) 1999-02-24 2002-02-05 Hoffmann La Roche Derivados de 3-fenilpiridina e seu uso como antagonista do receptor de nk-1
ES2226622T3 (es) 1999-02-24 2005-04-01 F. Hoffmann-La Roche Ag Derivados de 4-fenil piridina y su empleo como antagonistas del receptor nk-1.
PT1103545E (pt) 1999-11-29 2004-03-31 Hoffmann La Roche 2-(3,5-bis-trifluorometil-fenil)-n-metil-n-(6-morfolin-4-il-4-o-totil-piridin-3-il)-isobutiramida
RS50932B (sr) 2000-07-14 2010-08-31 F. Hoffmann-La Roche Ag. N-oksidi kao prolekovi 4-fenil-piridinskih derivata koji su antagonisti nk1 receptora
TWI287003B (en) 2000-07-24 2007-09-21 Hoffmann La Roche 4-phenyl-pyridine derivatives
TWI259180B (en) * 2000-08-08 2006-08-01 Hoffmann La Roche 4-Phenyl-pyridine derivatives
DK1385577T3 (da) 2001-04-23 2006-08-21 Hoffmann La Roche Anvendelse af NK-1-receptorantagonister mod godartet prostatahyperplasi
US20030083345A1 (en) 2001-07-10 2003-05-01 Torsten Hoffmann Method of treatment and/or prevention of brain, spinal or nerve injury
US6849624B2 (en) 2001-07-31 2005-02-01 Hoffmann-La Roche Inc. Aromatic and heteroaromatic substituted amides
JP4490421B2 (ja) * 2003-07-03 2010-06-23 エフ.ホフマン−ラ ロシュ アーゲー 統合失調症を処置するデュアルnk1/nk3アンタゴニスト
US20060030600A1 (en) 2004-08-06 2006-02-09 Patrick Schnider Dual NK1/NK3 receptor antagonists for the treatment of schizophrenia
BRPI0609699A2 (pt) 2005-03-23 2010-04-20 Hoffmann La Roche metabolitos para antatonistas de nk-1 para êmese
US7683056B2 (en) 2005-09-09 2010-03-23 Glaxosmithkline Llc Pyridine derivatives and their use in the treatment of psychotic disorders
WO2007039420A1 (en) 2005-09-23 2007-04-12 F. Hoffmann-La Roche Ag Novel dosage formulation
AR060403A1 (es) * 2006-04-12 2008-06-11 Sanofi Aventis Compuestos de amino- pirimidina 2,6- sustituidos -4- monosustituidos como antagonistas del receptor de prostaglandina d2
NZ574756A (en) * 2006-08-07 2011-03-31 Albany Molecular Res Inc 2-aminobenzoxazole carboxamides as 5ht3 modulators
GB0808747D0 (en) 2008-05-14 2008-06-18 Glaxo Wellcome Mfg Pte Ltd Novel compounds
WO2011054773A1 (en) 2009-11-03 2011-05-12 Glaxosmithkline Llc Novel lactam compounds
US8426450B1 (en) 2011-11-29 2013-04-23 Helsinn Healthcare Sa Substituted 4-phenyl pyridines having anti-emetic effect

Also Published As

Publication number Publication date
RU2016122464A (ru) 2017-12-11
RU2016122464A3 (pl) 2018-06-25
TWI657082B (zh) 2019-04-21
JP5806420B1 (ja) 2015-11-10
JPWO2015068744A1 (ja) 2017-03-09
RU2673084C2 (ru) 2018-11-22
US10100030B2 (en) 2018-10-16
US20160289206A1 (en) 2016-10-06
CN105745198A (zh) 2016-07-06
IL245286B (en) 2019-09-26
MX368070B (es) 2019-09-18
TW201605823A (zh) 2016-02-16
IL245286A0 (en) 2016-06-30
MX2016006004A (es) 2016-08-12
CA2930008A1 (en) 2015-05-14
AU2014347644B2 (en) 2018-06-14
AU2014347644A1 (en) 2016-05-19
KR20160078997A (ko) 2016-07-05
EP3067349A1 (en) 2016-09-14
ES2671418T3 (es) 2018-06-06
BR112016009811A2 (pt) 2017-12-05
EP3067349B1 (en) 2018-02-28
WO2015068744A1 (ja) 2015-05-14
EP3067349A4 (en) 2016-12-28
CN105745198B (zh) 2018-09-21

Similar Documents

Publication Publication Date Title
ZA201600514B (en) Quinoline derivative
IL240863A0 (en) Amatoxin derivatives
SG11201506100XA (en) Pyridazinone-amides derivatives
ZA201601333B (en) Oxoquinazolinyl-butanamide derivatives
SG11201600862YA (en) Piperidine urea derivatives
IL245286A0 (en) Consequence of piperidine carboxymethyl
SG11201605189YA (en) Imidazopyrazinone derivatives
ZA201405108B (en) Substituted phenylazole derivative
PL2803807T3 (pl) Drzwi
GB201313124D0 (en) Macerators
SG11201504474VA (en) Case unit
GB201300903D0 (en) Crystalline Form
GB201323188D0 (en) Waranlinc arm
PH32013001071S1 (en) Cigarette
GB201317405D0 (en) Door
IL229790A0 (en) swings
GB201301500D0 (en) Insulaton unit
AU348168S (en) A door
GB201303681D0 (en) Cyclosporin derivatives
GB201303685D0 (en) Cyclosporin derivatives